Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2

NCT05521048 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.

NCT NCT05521048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05521048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2
Lead sponsor
Massachusetts Eye and Ear Infirmary
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
September 19, 2022
Completion date
December 31, 2026
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 2